Drugs / Qishenyiqi dropping pills
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04028544 | Mar 2019 → Sep 2020 | heart failure | Chinese Academy of Medical Sciences, Fuwai Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT07604805 | Oct 2023 → Jun 2030 expected | idiopathic pulmonary arterial hypertension | Guangdong Provincial People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qishen Yiqi Dropping Pills | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07604805 ↗ |
| Known as | QSYQ | “standard treatment + Qishenyiqi dropping pills (QSYQ) (oral use, 1 bag each time, three times a day)” NCT04028544 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Qishen Yiqi Dropping Pills is an NMPA-approved Chinese patent medicine for cardiovascular diseases” NCT07604805 ↗ |
| Route | Oral | “Administration: 0.5g orally tid after meals.” NCT07604805 ↗ |